gip/glp-1 ra GLP-1 RA, and Type 2 Diabetes – Trend Diabetes GLP-1/GIP Tirzepatide Rx | FancyMeds

In a mouse model of Parkinsons disease, both lixisenatide and liraglitude are associated with neuroprotective benefits and reduced motor impairment by decreasing pro-apoptotic BAX signaling and increasing expression of anti-apoptotic Bcl-2 (Liu et al., 2015)

Providers may recommend: Treatment decisions should always be individualized

Shiau CW, Zhai D, Welsh K, Pinilla C, Nevzi A, Houghten R, Andreeff M , Huang Z, Reed J

Exercise preserves muscle loss in caloric deficits Being in a caloric deficit alone can result in 10%-30%, even 40% in some cases, of the weight lost from muscle mass

A.WebsterC

Additionally, their synergistic effects with existing clinical drugs can be explored